LON:VRCI

Verici Dx Share Forecast, Price & News

GBX 78

+0.50 (+0.65 %)

(As of 06/18/2021 12:00 AM ET)

Add

Compare

Today's Range

▼

50-Day Range

▼

52-Week Range

29.97

▼

94.95

Volume575 shs

Average Volume133,139 shs

Market Capitalization£110.56 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive VRCI News and Ratings via Email

Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter.

About Verici Dx

Verici Dx plc engages in developing and commercializing clinical diagnostics kidney transplant tests. The company was incorporated in 2020 and is based in Penarth, United Kingdom. As of July 10, 2020, Verici Dx plc is a former subsidiary of Renalytix AI plc.

Verici Dx (LON:VRCI) Shares Up 2.4%
June 3, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange LON
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolLON:VRCI
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.vericidx.com
Phone44 207 9338780
Employees8
Year FoundedN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueGBX 13.80 per share
Price / Book5.65

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares141,748,000
Market Cap£110.56 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Verici Dx.

0.0 Community Rank

Outperform Votes
Verici Dx has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Verici Dx has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Verici Dx and other stocks. Vote “Outperform” if you believe VRCI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VRCI will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Verici Dx does not currently pay a dividend.
Dividend Growth
Verici Dx does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Verici Dx insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Book Value per Share Ratio
Verici Dx has a P/B Ratio of 5.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Verici Dx (LON:VRCI) Frequently Asked Questions

What stocks does MarketBeat like better than Verici Dx?

Wall Street analysts have given Verici Dx a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Verici Dx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Verici Dx's key competitors?

Some companies that are related to Verici Dx include Akumin (AKU), Oncimmune (ONC), Yourgene Health (YGEN), LexaGene (LXG), SQI Diagnostics (SQD), Abingdon Health (ABDX), Cambridge Cognition (COG), genedrive (GDR), Sernova (SVA), GeneNews (GEN), Deepmatter Group (DMTR), LED Medical Diagnostics (LMD), Integrated Diagnostics (IDHC), VentriPoint Diagnostics (VPT) and Imaging Dynamics (IDL).
View all of VRCI's competitors.

What is Verici Dx's stock symbol?

Verici Dx trades on the London Stock Exchange (LON) under the ticker symbol "VRCI."

How do I buy shares of Verici Dx?

Shares of VRCI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verici Dx's stock price today?

One share of VRCI stock can currently be purchased for approximately GBX 78.

How much money does Verici Dx make?

Verici Dx has a market capitalization of £110.56 million.

How many employees does Verici Dx have?

Verici Dx employs 8 workers across the globe.

What is Verici Dx's official website?

The official website for Verici Dx is www.vericidx.com.

How can I contact Verici Dx?

The company can be reached via phone at 44 207 9338780.

This page was last updated on 6/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.